evAluation of Glycemic RangE During acutE Coronary syndroME in Nondiabetic paTients
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 196
- 试验地点
- 2
- 主要终点
- Glycemic status
研究概览
简要总结
To evaluate the glycemic variations during acute coronary syndrome in non-diabetic patients (euglycemic, or with impaired fasting glucose, or with impaired glucose tolerance)
详细描述
All nondiabetic patients with dysglycemia (fasting plasma glucose between 100 and 125 mg/dl) will be monitored with a device (Continuous Glucose Monitoring System) and all these patients will be undergone an oral glucose tolerance test after the discharge from this Unit.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
盲法说明
CGMS
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •nondiabetic patients
- •acute coronary syndrome
排除标准
- •diabetic patients
结局指标
主要结局
Glycemic status
时间窗: 15 days
Patients with dysglycemia (not diabetic patients) will be undergone a monitoring of blood glucose with a device till the discharge of the patient. Then, an oral glucose tolerance test (OGTT) will be done to categorize the patient as having impaired fasting glucose (IFG) or impaired glucose tolerance (IGT), or diabetes mellitus.
次要结局
- Inflammation parameters(15 days)
- Lipid profile(15 days)
- Endothelial damage(15 days)
- Heart damage(15 days)
研究者
Giuseppe Derosa
MD, PhD, FESC
University of Pavia